A Resolution urging the Congress of the United States to expand post-traumatic stress disorder treatment for veterans and service members by authorizing stellate ganglion block therapy through passage of H.R. 1947, the Treatment and Relief through Emerging and Accessible Therapy for PTSD Act.

This resolution (SR 122) urges Congress to pass H.R. 1947, which would authorize the U.S. Department of Veterans Affairs and Department of Defense to provide stellate ganglion block (SGB) therapy to veterans and service members with PTSD. SGB is a low-risk nerve block procedure proven to reduce PTSD symptoms like anxiety and hyperarousal, currently available to only 40% of veterans through existing treatments. The resolution highlights that untreated PTSD correlates with higher suicide risk, with 20 veteran suicides occurring daily in the U.S. It specifically requests Congress expand access to SGB therapy as an additional treatment option for veterans diagnosed with PTSD. This is a non-binding resolution, not a law, directing the Senate to formally recommend passage of H.R. 1947.